- In March 2024, ResMed launched its next-generation AirSense 11 AutoSet CPAP device, integrated with digital health features including remote patient monitoring and AI-driven therapy adjustments. This launch reflects ResMed’s ongoing commitment to personalizing sleep apnea treatment and improving adherence through user-friendly interfaces and connected care platforms
- In February 2024, Koninklijke Philips N.V. announced the global rollout of its DreamStation 2 CPAP system with enhanced humidification and a streamlined patient setup process. The updated device is designed to improve user comfort and therapy acceptance rates, aligning with the growing demand for home-based sleep solutions
- In January 2024, Fisher & Paykel Healthcare Limited introduced a new CPAP mask series—Evora Full—featuring minimal-contact headgear and dynamic support technology. The innovation addresses common complaints about discomfort and leakage, enhancing patient satisfaction and long-term compliance
- In November 2023, Drive DeVilbiss Healthcare unveiled the IntelliPAP 3 AutoAdjust CPAP system in key North American and European markets. The device offers real-time performance analytics and Bluetooth integration for remote clinical oversight, catering to the rising emphasis on digital therapeutics in sleep care
- In October 2023, BMC Medical Co., Ltd. launched the G3 B25VT BiPAP system in Asia-Pacific markets. With features such as built-in humidifiers and smart pressure relief modes, the system supports both obstructive sleep apnea and complex respiratory conditions, positioning BMC for broader global expansion
- In September 2023, React Health announced a strategic partnership with sleep centers across the U.S. to pilot its new CPAP cloud platform “ReactCare,” designed to provide seamless data sharing between patients, providers, and payers, improving therapy optimization and reducing non-adherence
